Spectrum Planning & Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
558
-358
-39% -$123K 0.09% 114
2026
Q1
$322K Sell
916
-75
-8% -$26.7K 0.16% 82
2025
Q4
$324K Buy
991
+6
+0.6% +$1.9K 0.17% 88
2025
Q3
$278K Buy
985
+66
+7% +$19.1K 0.16% 88
2025
Q2
$257K Buy
+919
New +$260K 0.17% 87

Other funds holding AMGN

Spectrum Planning & Advisory Services's AMGN Position: Q2 2026 in Review

Spectrum Planning & Advisory Services reduced its Amgen (AMGN) stake by 39% in Q2 2026, selling an estimated $123K and leaving 558 shares worth $202K. The position accounts for 0.09% of the portfolio, ranked #114.

Spectrum Planning & Advisory Services first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $324K in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Spectrum Planning & Advisory Services held 558 shares of Amgen worth $202K as of Q2 2026.
  • Spectrum Planning & Advisory Services sold 358 Amgen shares in Q2 2026, an estimated $123K.
  • Amgen made up 0.09% of Spectrum Planning & Advisory Services's portfolio in Q2 2026, its #114 holding.
  • Spectrum Planning & Advisory Services first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Spectrum Planning & Advisory Services's Amgen position peaked at $324K in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Spectrum Planning & Advisory Services's 13F filing for Q2 2026, filed 14 Jul 2026.